2 ASX All Ordinaries stocks leaping higher following strong quarters

Let's dive into why these All Ords shares are besting the index on Thursday.

| More on:
Man pointing at a blue rising share price graph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is having a rough session on Thursday, but two stocks are defying the slump.

While the All Ords is falling 0.4% to 7,472.9 points, these stocks are leaping as much as 7% on the back of strong quarterly updates.

2 ASX All Ordinaries stocks surging on quarterly updates

Helloworld Travel Ltd (ASX: HLO)

First up, All Ordinaries travel stock Helloworld is soaring 7.43% today to trade at $2.89.

It comes on news the company's underlying earnings before interest, tax, depreciation, and amortisation (EBITDA) jumped to $14.2 million last quarter. That's up from a $4.9 million loss in the prior comparable period.

Its total transaction value (TTV) also shot 150% higher to $596.2 million while its revenue launched 240% to $46.9 million.

Also excitingly, Helloworld bolstered its full-year guidance on the back of its strong performance.

It now expects to post between $38 million and $42 million of underlying EBITDA for financial year 2023 – a $10 million improvement on its previous forecasts.

Incannex Healthcare Ltd (ASX: IHL)

Joining Helloworld stock in the green is that of Incannex. The pharmaceutical development company's share price is roaring 4.35% higher to trade at 12 cents at the time of writing.

The company released its update on the March quarter this morning, within which it narrowed the timeframe for the commercialisation of its psychedelic-assisted psychotherapy business, Psychedelic Clinics.

The first 'model' clinic is on track to be ready to open in Melbourne before September. It will be capable of treating over 600 patients per year during normal working hours.

The company also continued activities associated with the dosing of trial participants in its bioavailability and bioequivalence (BA/BE) clinical trial, assessing the pharmacokinetics and tolerability of the two active pharmaceutical ingredients in IHL-42X.

It's aiming to submit an investigational new drug (IND) application with the US Food and Drug Administration (FDA) this quarter.

Incannex posted around $4.3 million of cash outflows last quarter to end the period with $37.1 million of cash.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Helloworld Travel. The Motley Fool Australia has positions in and has recommended Helloworld Travel. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX had a very pleasant end to the trading week this Friday.

Read more »

A woman holds her hand out under a graphic hologram image of a human brain with brightly lit segments and section points.
Share Gainers

The Brainchip share price is up 213% this month. Is Nvidia to blame?

The small cap Aussie tech stock is going bananas in 2024.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Aussie Broadband, Australian Ethical, Jumbo, and Vulcan are racing higher

These ASX shares are ending the week on a high. But why?

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Share Gainers

Why Bega Cheese, Domino's, Lovisa, and Universal Store shares are rocketing today

These ASX shares are catching the eye on Thursday. But why?

Read more »

A smiling man at a shop counter takes payment from a female customer, with racks of plants in the background.
Share Gainers

The Wesfarmers share price is rising again. Should I buy the stock now?

The conglomerate reported warmly received results last week and announced a large dividend.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Share Gainers

If you'd put $20,000 in this ASX healthcare stock during COVID-19, you'd have $257,000 now

You could have become filthy rich in just 4 years. Just think about that.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Codan, Domino's, Lottery Corp, and Wisetech shares are storming higher today

These ASX shares are avoiding the market weakness today. But why?

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors endured a mildly negative session on the stock market this Tuesday.

Read more »